Platelet activation as a potential mechanism of GP IIb/IIIa inhibitor-induced thrombocytopenia
Authors:
- Karlheinz PeterKPKarlheinz Peter
- Andreas StraubASAndreas Straub
- Benedikt KohlerBKBenedikt Kohler
- Martin VolkmannMVMartin Volkmann
- Meike SchwarzMSMeike Schwarz
- Wolfgang KüblerWKWolfgang Kübler
- Christoph BodeCBChristoph Bode
- 1 September 1999
- journal article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 84 (5) , 519-524
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Platelet GPIIb-IIIa blockersThe Lancet, 1999
- Association Between Ligand-Induced Conformational Changes of Integrin IIbβ3 and IIbβ3-Mediated Intracellular Ca2+ SignalingBlood, 1998
- Induction of Fibrinogen Binding and Platelet Aggregation as a Potential Intrinsic Property of Various Glycoprotein IIb/IIIa (IIbβ3) InhibitorsBlood, 1998
- Drug-Induced Thrombocytopenia: Is it a Serious Concern for Glycoprotein IIb/IIIa Receptor Inhibitors?Journal of Thrombosis and Thrombolysis, 1998
- Oral Platelet Glycoprotein IIb/IIIa Receptor Antagonists: The Present Challenge Is SafetyCirculation, 1998
- Acute Profound Thrombocytopenia After c7E3 Fab (Abciximab) TherapyCirculation, 1997
- Abciximab-associated profound thrombocytopenia: Therapy with immunoglobulin and platelet transfusionThe American Journal of Cardiology, 1996
- Platelet Glycoprotein IIb/IIIa Receptors in Cardiovascular MedicineNew England Journal of Medicine, 1995
- Synergistic Roles for Receptor Occupancy and Aggregation in Integrin Transmembrane FunctionScience, 1995
- Ligands “activate” integrin αIIbβ3 (platelet GPIIb-IIIa)Cell, 1991